Schellenberg Wittmer has provided legal counsel to Santhera Pharmaceuticals Holding in the sale of its Raxone®/idebenone business for all indications worldwide to Chiesi Farmaceutici. The deal marks a significant update to the existing license
Lenz & Staehelin acted as legal advisors for Elos Medtech, a development and manufacturing partner for medical devices, on its recent expansion through its agreement to acquire Klingel Holding. The acquisition is valued at EUR 370
Walder Wyss acted as legal counsel to Ionisos SAS on its recent acquisition of an E-beam sterilization and cross-linking facility from Studer Cables. Studer Cables, a prominent technology company specializing in high-performance cables for various
Homburger has provided legal counsel to Santhera Pharmaceuticals Holding (SIX: SANN “Santhera”) on its completion of a 10:1 reverse split of its shares. The reverse split, which was approved by shareholders on June 27, 2023, resulted in the
Ironwood Pharmaceuticals (Nasdaq: IRWD), a healthcare company specializing in GI treatments, and VectivBio Holding (Nasdaq: VECT), a clinical-stage biopharmaceutical company focused on developing innovative therapies for severe rare gastrointestinal conditions, have reached an agreement where&
Walder Wyss team advised the funds managed by Pharmakon Advisors, LP, in connection with the closing of the term loan financing of Reata Pharmaceuticals for up to USD 275 million. Reata Pharmaceuticals, is a global biopharmaceutical
Hasten Biopharmaceutic (China) has acquired the commercial rights in China for Rocephin®, a long-acting, broad spectrum cephalosporin antibiotic, from Swiss multinational healthcare company, Roche. Under the agreement, Hasten acquired Roche’s China mainland rights for
Walder Wyss has taken on the role of data protection officer advisor of Swisstransplant. In this capacity, the firm supports Swisstransplant in conducting data protection assessments and implementing measures to ensure compliance under the upcoming
Samsung Ventures has made a strategic investment in Araris Biotech. The investment corporation, that was established to promote the development of new technologies, has invested in the company in an independent deal ahead of its
Niederer Kraft Frey (NKF) advised Ascend Capital Partners on its series A investment in NanoFlex Robotics. Nanoflex is developing a robotic system that allows the precise movement of specially made catheters using electromagnetic controls. The
